Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 97 pages | ID: GB01F5459457EN
QYResearch

Abstracts

This report focuses on the global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• AstraZeneca
• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Novartis AG
• Merck & Co., Inc.
• Daiichi Sankyo Company, Limited
• AB Sciences

Market segment by Type, the product can be split into

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy

Market segment by Application, split into

• Opdivo
• Yervoy
• Mekinist+Tafinlar
• Keytruda
• Cotellic
• Zelboraf
• Imlygic
• Generics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Melanoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Melanoma Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Melanoma Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Melanoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chemotherapy
  1.4.3 Immunotherapy
  1.4.4 Targeted Therapy
  1.4.5 Radiation Therapy
1.5 Market by Application
  1.5.1 Global Melanoma Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Opdivo
  1.5.3 Yervoy
  1.5.4 Mekinist+Tafinlar
  1.5.5 Keytruda
  1.5.6 Cotellic
  1.5.7 Zelboraf
  1.5.8 Imlygic
  1.5.9 Generics
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Melanoma Therapeutics Market Perspective (2015-2026)
2.2 Melanoma Therapeutics Growth Trends by Regions
  2.2.1 Melanoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Melanoma Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Melanoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Melanoma Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Melanoma Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Melanoma Therapeutics Players by Market Size
  3.1.1 Global Top Melanoma Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Melanoma Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Melanoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Melanoma Therapeutics Market Concentration Ratio
  3.2.1 Global Melanoma Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Melanoma Therapeutics Revenue in 2019
3.3 Melanoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Melanoma Therapeutics Product Solution and Service
3.5 Date of Enter into Melanoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Melanoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Melanoma Therapeutics Forecasted Market Size by Type (2021-2026)

5 MELANOMA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Melanoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Melanoma Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Melanoma Therapeutics Market Size (2015-2020)
6.2 Melanoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Melanoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Melanoma Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Melanoma Therapeutics Market Size (2015-2020)
7.2 Melanoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Melanoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Melanoma Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Melanoma Therapeutics Market Size (2015-2020)
8.2 Melanoma Therapeutics Key Players in China (2019-2020)
8.3 China Melanoma Therapeutics Market Size by Type (2015-2020)
8.4 China Melanoma Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Melanoma Therapeutics Market Size (2015-2020)
9.2 Melanoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Melanoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Melanoma Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Melanoma Therapeutics Market Size (2015-2020)
10.2 Melanoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Melanoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Melanoma Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Melanoma Therapeutics Market Size (2015-2020)
11.2 Melanoma Therapeutics Key Players in India (2019-2020)
11.3 India Melanoma Therapeutics Market Size by Type (2015-2020)
11.4 India Melanoma Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Melanoma Therapeutics Market Size (2015-2020)
12.2 Melanoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Melanoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Melanoma Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Details
  13.1.2 AstraZeneca Business Overview and Its Total Revenue
  13.1.3 AstraZeneca Melanoma Therapeutics Introduction
  13.1.4 AstraZeneca Revenue in Melanoma Therapeutics Business (2015-2020))
  13.1.5 AstraZeneca Recent Development
13.2 Amgen, Inc.
  13.2.1 Amgen, Inc. Company Details
  13.2.2 Amgen, Inc. Business Overview and Its Total Revenue
  13.2.3 Amgen, Inc. Melanoma Therapeutics Introduction
  13.2.4 Amgen, Inc. Revenue in Melanoma Therapeutics Business (2015-2020)
  13.2.5 Amgen, Inc. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
  13.3.1 F. Hoffmann-La Roche Ltd. Company Details
  13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.3.3 F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Introduction
  13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Melanoma Therapeutics Business (2015-2020)
  13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 Bristol-Myers Squibb Company
  13.4.1 Bristol-Myers Squibb Company Company Details
  13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.4.3 Bristol-Myers Squibb Company Melanoma Therapeutics Introduction
  13.4.4 Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2015-2020)
  13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Novartis AG
  13.5.1 Novartis AG Company Details
  13.5.2 Novartis AG Business Overview and Its Total Revenue
  13.5.3 Novartis AG Melanoma Therapeutics Introduction
  13.5.4 Novartis AG Revenue in Melanoma Therapeutics Business (2015-2020)
  13.5.5 Novartis AG Recent Development
13.6 Merck & Co., Inc.
  13.6.1 Merck & Co., Inc. Company Details
  13.6.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.6.3 Merck & Co., Inc. Melanoma Therapeutics Introduction
  13.6.4 Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2015-2020)
  13.6.5 Merck & Co., Inc. Recent Development
13.7 Daiichi Sankyo Company, Limited
  13.7.1 Daiichi Sankyo Company, Limited Company Details
  13.7.2 Daiichi Sankyo Company, Limited Business Overview and Its Total Revenue
  13.7.3 Daiichi Sankyo Company, Limited Melanoma Therapeutics Introduction
  13.7.4 Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2015-2020)
  13.7.5 Daiichi Sankyo Company, Limited Recent Development
13.8 AB Sciences
  13.8.1 AB Sciences Company Details
  13.8.2 AB Sciences Business Overview and Its Total Revenue
  13.8.3 AB Sciences Melanoma Therapeutics Introduction
  13.8.4 AB Sciences Revenue in Melanoma Therapeutics Business (2015-2020)
  13.8.5 AB Sciences Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Melanoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Melanoma Therapeutics Revenue
Table 3. Ranking of Global Top Melanoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Melanoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Immunotherapy
Table 7. Key Players of Targeted Therapy
Table 8. Key Players of Radiation Therapy
Table 9. Global Melanoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Melanoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Melanoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Melanoma Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Melanoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Melanoma Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Melanoma Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Melanoma Therapeutics Players
Table 20. Global Melanoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Melanoma Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Melanoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Therapeutics as of 2019)
Table 23. Global Melanoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Melanoma Therapeutics Product Solution and Service
Table 26. Date of Enter into Melanoma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Melanoma Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Melanoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Melanoma Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Melanoma Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 36. North America Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Melanoma Therapeutics Market Share by Type (2015-2020)
Table 38. North America Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Melanoma Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 42. Europe Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Melanoma Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Melanoma Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 48. China Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Melanoma Therapeutics Market Share by Type (2015-2020)
Table 50. China Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Melanoma Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 54. Japan Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Melanoma Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Melanoma Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Melanoma Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Melanoma Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 66. India Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Melanoma Therapeutics Market Share by Type (2015-2020)
Table 68. India Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Melanoma Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Melanoma Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Melanoma Therapeutics Market Share (2019-2020)
Table 72. Central & South America Melanoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Melanoma Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Melanoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Melanoma Therapeutics Market Share by Application (2015-2020)
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Product
Table 79. AstraZeneca Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 80. AstraZeneca Recent Development
Table 81. Amgen, Inc. Company Details
Table 82. Amgen, Inc. Business Overview
Table 83. Amgen, Inc. Product
Table 84. Amgen, Inc. Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 85. Amgen, Inc. Recent Development
Table 86. F. Hoffmann-La Roche Ltd. Company Details
Table 87. F. Hoffmann-La Roche Ltd. Business Overview
Table 88. F. Hoffmann-La Roche Ltd. Product
Table 89. F. Hoffmann-La Roche Ltd. Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 90. F. Hoffmann-La Roche Ltd. Recent Development
Table 91. Bristol-Myers Squibb Company Company Details
Table 92. Bristol-Myers Squibb Company Business Overview
Table 93. Bristol-Myers Squibb Company Product
Table 94. Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 95. Bristol-Myers Squibb Company Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Product
Table 99. Novartis AG Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 100. Novartis AG Recent Development
Table 101. Merck & Co., Inc. Company Details
Table 102. Merck & Co., Inc. Business Overview
Table 103. Merck & Co., Inc. Product
Table 104. Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 105. Merck & Co., Inc. Recent Development
Table 106. Daiichi Sankyo Company, Limited Company Details
Table 107. Daiichi Sankyo Company, Limited Business Overview
Table 108. Daiichi Sankyo Company, Limited Product
Table 109. Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 110. Daiichi Sankyo Company, Limited Recent Development
Table 111. AB Sciences Business Overview
Table 112. AB Sciences Product
Table 113. AB Sciences Company Details
Table 114. AB Sciences Revenue in Melanoma Therapeutics Business (2015-2020) (Million US$)
Table 115. AB Sciences Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Melanoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Melanoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Opdivo Case Studies
Figure 8. Yervoy Case Studies
Figure 9. Mekinist+Tafinlar Case Studies
Figure 10. Keytruda Case Studies
Figure 11. Cotellic Case Studies
Figure 12. Zelboraf Case Studies
Figure 13. Imlygic Case Studies
Figure 14. Generics Case Studies
Figure 15. Melanoma Therapeutics Report Years Considered
Figure 16. Global Melanoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Melanoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 18. Global Melanoma Therapeutics Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Melanoma Therapeutics Market Share by Players in 2019
Figure 21. Global Top Melanoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Therapeutics as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Melanoma Therapeutics Revenue in 2019
Figure 23. North America Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Melanoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AstraZeneca Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 32. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Amgen, Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 34. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 36. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Company Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 38. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Novartis AG Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 40. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck & Co., Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 42. Daiichi Sankyo Company, Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Daiichi Sankyo Company, Limited Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 44. AB Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. AB Sciences Revenue Growth Rate in Melanoma Therapeutics Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed